title: Pharmacist medication reviews to improve safety monitoring in primary care patients.
abstract: OBJECTIVE
  Patients prescribed psychotropic medications within primary care are at risk of suboptimal monitoring. It is unknown whether pharmacists can improve medication safety through targeted monitoring of at risk populations. Access Community Health Centers implemented a quality improvement pilot project that included pharmacists on an integrated care team to provide medication reviews for patients. Aims were to determine whether inclusion of a pharmacist performing medication reviews within a primary care behavioral health (PCBH) practice is feasible and facilitates safe medication use.
  
  
  METHODS
  Pharmacists performed medication reviews of the electronic health record for patients referred for psychiatry consultation. Reviews were performed 1-3 months following consultation and focused on medications with known suboptimal monitoring rates. Reviews were documented within the EHR and routed to the primary care provider. Primary outcome measures were change in percentage up-to-date on monitoring and AIMS assessment, and at risk of experiencing drug interaction(s) between baseline and 3 months postreview. Secondary outcome was provider opinion of medication reviews collected via electronic survey.
  
  
  RESULTS
  Reviews were performed for 144 patients. Three months postreview, percentage up-to-date on recommended monitoring increased 18% (p = .0001), at risk for drug interaction decreased 20% (p < .0001), and up-to-date on AIMS decreased 12% (p = .2113). The majority of surveyed providers wanted medication reviews to continue.
  
  
  CONCLUSIONS
  Pharmacist population-level monitoring within an integrated care team is feasible and associated with improved safety monitoring of psychotropic medications. Results identify key areas for improvement that other clinics considering integration of similar pharmacy services should consider. (PsycINFO Database Record
authors.affiliation: School of Pharmacy, University of Wisconsin-Madison.
authors.forename: Casey E
authors.initials: CE
authors.lastname: Gallimore
authors.affiliation: School of Pharmacy, University of Wisconsin-Madison.
authors.forename: Dimmy
authors.initials: D
authors.lastname: Sokhal
authors.affiliation: Access Community Health Centers.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Zeidler Schreiter
authors.affiliation: School of Pharmacy, University of Wisconsin-Madison.
authors.forename: Amanda R
authors.initials: AR
authors.lastname: Margolis
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D008875:Middle Aged; D010595:Pharmacists / Q000523:psychology / Q000592:standards*; D000069437:Pharmacological Phenomena; D011320:Primary Health Care / Q000379:methods; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use; D012017:Referral and Consultation / Q000592:standards; D017751:Safety Management / Q000379:methods* / Q000592:standards
chemical_list: D011619:Psychotropic Drugs